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Knowledge can flow from developing to developed countries
Editor—I am pleased that this issue of the
BMJ explores the many aspects of research
in developing countries. The first thing that
comes to mind on this issue is how
developed countries can teach developing
countries, but few people realise that the
flow of knowledge can sometimes be
reversed. Developed countries can learn and
benefit from research in developing coun›
tries, particularly from research on infec›
tious diseases and alternative treatments.
More international travel has led to a
resurgence of infectious diseases and to a
rapid spread to developed countries of
diseases that used to be exclusive to the devel›
oping world. The emergence of HIV infec›
tion has warned us about the global threat of
new infections, which are more likely to start
in developing countries.1 Research and
surveillance on infectious diseases are most
effectively done in areas where the diseases
are common. Early communication and
attention to this epidemiological information
from developing countries can prevent
potential global disasters.
The different needs and healthcare
settings in developing countries often stimu›
late new treatment methods, some of which
can be more cost effective than established
practices in developed countries. Directly
observed therapy, short term (DOTS) for
tuberculosis was shown to be effective in
Africa and Asia in the early 1950s and has
been the standard method of treatment in
Hong Kong since then. It was only in 1993
that the US Centers for Disease Control
recommended it be considered for all
patients with tuberculosis.2 Earlier adoption
of this research evidence might have
prevented some of the deaths and multiple
drug resistance associated with tuberculosis
in many developed countries in recent years.
Traditional medical practices in devel›
oping countries can be a treasure box of
alternative or complementary treatments
for people in developed countries. Research
on the effectiveness of acupuncture has
made it a standard treatment in many devel›
oped countries. Qing hao su, a Chinese
herbal medicine, has been proved to be an
effective and safe treatment for malaria.3
Trials of many Chinese herbal medicines for
the treatment of HIV infection and cancer
are currently under way.
The lack of advanced technology and
sophisticated equipment may limit the quality
and scope of some research in developing
countries, but a lot of knowledge can be
acquired through careful observations and
innovative ideas, which do not need a lot of
money. Mutual exchange is a more satisfying
process than one›way transfer of knowledge
and resources. Developed countries will get
more in return for their investments in
research in developing countries if they are
more receptive to findings from these
countries.
Cindy L K Lam associate professor
Family Medicine Unit, Department of Medicine,
University of Hong Kong 3/F, Ap Lei Chau Clinic,
Hong Kong SAR, China
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Let’s consider ethics of medical
practice first
Editor—During the past year I have
attended three meetings on the ethics of
research sponsored by the World Health
Organization, the Harvard School of Public
Health, and the Indian Council of Medical
Research. They were all ignored by the
media, although the Indian media report
daily on the poor state of the health service
and unethical medical practices. The recent
alleged maltreatment of a central govern›
ment minister who died in a private hospital
in Delhi has caused particular public
concern.1
That medical research in developing
countries is meagre and of generally poor
quality is well known,2 and it has not
improved in the past 20 years. Should one
therefore discuss research ethics in develop›
ing countries when they barely exist?
In my view the ethics of medical practice
is more important. To see how the public can
be safeguarded from an inefficient and often
corrupt medical system and receive compre›
hensive health care of a reasonable quality is
paramount. Ordinary people have to choose
between an underfunded and inefficient pub›
lic sector with its long queues, dirty hospitals,
and rude staff (not infrequently on strike for
more pay) and the expensive private sector,
perceived as being run by avaricious doctors
fleecing patients through overinvestigation
and overtreatment. Many patients, under›
standably, turn to the more accessible and
cheaper practitioners of alternative systems
of medicine or even to quacks, who regularly
prescribe a cocktail of antibiotics, antimalar›
ials, antipyretics, and steroids for fever.
Despite this, 80% of the Indian gross domes›
tic project spent on health care goes to the
private sector.3
The medical councils, the main regula›
tory bodies, are generally ineffective, claim›
ing that they do not have the necessary
powers. Only one doctor (a well known actor
who used his medical status in an advertise›
ment) has been struck off since their
inception. Even the Consumer Protection
Act, which includes medical practitioners in
its ambit, has not successfully curbed unethi›
cal medical practices because of the huge
delays in its legal process.
In January 2000 the Ministry of Health
recognised the growing concern about the
absence of standards to measure the quality
of health services and that the medical com›
munity in India is not accountable in any
manner. It proposed setting up a system of
monitoring hospitals and doctors in both
the public and private sectors. Perhaps the
sad and unfortunate death of a young
minister will now result in some belated
action.
Samiran Nundy gastrointestinal surgeon
Sir Ganga Ram Hospital, New Delhi 110060, India
snundy@hotmail.com
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